FENTANYL CITRATE AND DROPERIDOL Drug Patent Profile
Which patents cover Fentanyl Citrate And Droperidol, and what generic alternatives are available?
Fentanyl Citrate And Droperidol is a drug marketed by Astrazeneca and Hospira and is included in four NDAs.
The generic ingredient in FENTANYL CITRATE AND DROPERIDOL is droperidol; fentanyl citrate. There is one drug master file entry for this compound. Additional details are available on the droperidol; fentanyl citrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FENTANYL CITRATE AND DROPERIDOL?
- What are the global sales for FENTANYL CITRATE AND DROPERIDOL?
- What is Average Wholesale Price for FENTANYL CITRATE AND DROPERIDOL?
Summary for FENTANYL CITRATE AND DROPERIDOL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 7 |
| DailyMed Link: | FENTANYL CITRATE AND DROPERIDOL at DailyMed |
US Patents and Regulatory Information for FENTANYL CITRATE AND DROPERIDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072026-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 071982-001 | May 4, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072027-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | FENTANYL CITRATE AND DROPERIDOL | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 072028-001 | Apr 13, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
